🇺🇸 FDA

Drug profile · INN

diphenhydramine citrate

IBUPROFEN AND DIPHENHYDRAMINE CITRATE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

diphenhydramine citrate (IBUPROFEN AND DIPHENHYDRAMINE CITRATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN diphenhydramine citrate
Brand IBUPROFEN AND DIPHENHYDRAMINE CITRATE
Route ORAL
Formulation TABLET

Frequently asked questions

What is diphenhydramine citrate?

diphenhydramine citrate (IBUPROFEN AND DIPHENHYDRAMINE CITRATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for diphenhydramine citrate?

IBUPROFEN AND DIPHENHYDRAMINE CITRATE is a marketed brand name for diphenhydramine citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of diphenhydramine citrate?

diphenhydramine citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.